Welcome to our dedicated page for SCHWAB CHARLES SEC filings (Ticker: SCHW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SCHWAB CHARLES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SCHWAB CHARLES's regulatory disclosures and financial reporting.
Charles R. Schwab, identified as Co-Chairman and a director of The Charles Schwab Corporation (SCHW), reported sales of common stock on 08/26/2025 and 08/27/2025. The Form 4 shows a sale of 136,500 shares on 08/26/2025 at a weighted average price of $96.666 and a sale of 136,500 shares on 08/27/2025 at a weighted average price of $97.044. Beneficial ownership lines reported after the transactions list 56,467,949 shares and 56,331,449 shares, respectively, held indirectly by trusts, plus additional indirect holdings described as 9,509,797.33 shares by spouse as trustee, 30,641,981 by a limited partnership, and 44,025 by 188 Corp. The form is signed by attorney-in-fact P. Blake Allen on 08/28/2025.
The Charles Schwab Corporation (SCHW) Form 144 notifies the planned sale of 13,216 common shares on 08/28/2025 through The Charles Schwab Corporation as broker on the NYSE, with an aggregate market value of $1,309,865.00. The filing states these shares were acquired on 08/28/2025 via various stock option exercises and sales, and payment was completed on that date. The filer previously sold 3,296 shares on 08/27/2025 for $320,305.00. Outstanding shares are listed as 1,815,219,300, showing the planned sale represents a de minimis fraction of total shares.
The filing reports that Carolyn Schwab-Pomerantz, a director of The Charles Schwab Corporation (SCHW), sold 13,542 shares of SCHW common stock on 08/25/2025 in multiple trades at weighted average price $96.0569 per share. The report lists post-transaction beneficial ownership across several accounts: 1,463,656.6599 shares indirectly held by a trust, 460,114 shares indirectly held by spouse as trustee, 2,798 shares indirectly held by an LLC, and 9,624 shares directly held. The form was signed by attorney-in-fact P. Blake Allen on 08/27/2025. The filer states availability to provide detailed trade-level information on request.
Form 144 filing for The Charles Schwab Corporation (SCHW) reports a proposed sale of 3,296 common shares by the reporting person, acquired as restricted stock units on 03/01/2023 (and noted RSUs also from 03/01/2024). The filing lists an aggregate market value of $320,305 for the shares and shows approximately 1,815,219,300 shares outstanding for the issuer. The broker is listed as The Charles Schwab Corporation, Westlake TX and the approximate sale date is 08/27/2025 on the NYSE. The filer also disclosed a recent sale on 05/30/2025 of 2,850 shares for gross proceeds of $249,572. The signer affirms they are not aware of any material nonpublic information about the issuer.
The filing notifies a proposed sale of 50,016 shares of The Charles Schwab Corporation common stock with an aggregate market value of $4,852,552.00. The shares are scheduled for sale on the NYSE on 08/27/2025. The filing shows the shares were acquired the same day, 08/27/2025, via a stock option granted by the issuer and paid on that date. No other sales by the reporting person were reported in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Form 144 notice filed for The Charles Schwab Corporation (SCHW) documents proposed and completed sales of common stock by Charles R. Schwab. The filing shows a proposed sale of 136,500 shares (approximate aggregate market value $13,254,150) on 08/27/2025 to be executed on the NYSE. Acquisition details show these shares were acquired in a leveraged buyout on 03/31/1987. The filing also reports three sales by Charles R. Schwab in the prior three months: 22,721 shares (08/07/2025, $2,181,610), 133,153 shares (08/08/2025, $12,888,080), and 136,500 shares (08/26/2025, $13,194,903). The filer certifies no undisclosed material adverse information is known.
The Charles Schwab Corporation (SCHW) Form 144 notifies the SEC of a proposed insider sale of 136,500 shares of common stock to be sold approximately on 08/26/2025 through The Charles Schwab Corporation broker on the NYSE, with an aggregate market value listed at $13,138,125.00. The filer indicates these shares were acquired on 03/31/1987 in a leveraged buyout. The filing also discloses two recent sales by the same person in early August 2025: 22,721 shares on 08/07/2025 for $2,181,610.00 and 133,153 shares on 08/08/2025 for $12,888,080.00. The notice includes the required representation that the seller knows of no undisclosed material adverse information.
The Charles Schwab Corporation (SCHW) Form 144 notifies the market that Carolyn S. Pomerantz intends to sell 13,542 shares of common stock, scheduled approximately for 08/25/2025 on the NYSE with an aggregate market value shown as $1,302,009.00. The shares were acquired as a gift from Charles R. Schwab on 02/14/2022; the donor originally acquired the stock on 11/26/1986.
The filing also discloses three prior sales by the same seller in the past three months: 24,000 shares sold on each of 06/05/2025, 07/03/2025, and 08/07/2025 with gross proceeds of $2,093,956, $2,198,154, and $2,320,656 respectively. The filer certifies no undisclosed material adverse information.
Charles R. Schwab, Co-Chairman and director of The Charles Schwab Corporation, reported discrete sales of company common stock on 08/07/2025 and 08/08/2025. The Form 4 shows sales of 22,721 shares on 08/07/2025 at a weighted-average price of $96.0174, and two sales on 08/08/2025 of 28,653 shares at a weighted-average price of $96.6019 and 104,500 shares at a weighted-average price of $96.8435. Aggregated sales reported on the form total 155,874 shares. The filing lists the amount of securities beneficially owned following the reported transactions as 56,604,449 shares (indirect, by trust), and separately discloses related indirect holdings of 9,509,797.33 shares by spouse as trustee, 30,641,981 shares by a limited partnership, and 44,025 shares by 188 Corp. The explanatory notes state the reported prices reflect weighted-average sale prices executed in multiple trades.
Carolyn Schwab-Pomerantz, a director of The Charles Schwab Corporation (SCHW), reported multiple sales of common stock executed on 08/07/2025 under a Rule 10b5-1 trading plan adopted August 14, 2024. The Form 4 shows sales of 14,000 and 400 shares held indirectly by a trust at weighted-average prices of $96.6799 and $97.22, and sales of 9,400 and 200 shares held indirectly by a spouse-as-trustee at weighted-average prices of $96.6818 and $97.205. The filings list resulting indirect beneficial holdings in the ranges of 1,477,598.6599 and 460,114–460,314 shares depending on account designation. The explanatory note discloses the execution price ranges and offers to provide full trade details on request.